Abstract
Hormonal responses were assessed in men with prostate cancer (T2-4, Nx, Mx) who were randomized to receive either a single injection of goserelin 3.6 mg or leuprolide 3.75 mg. Testosterone increased over the first week, with a significantly higher mean rate of change of total testosterone (day 3) and free testosterone (days 3 and 7) with leuprolide. Following the initial rise in luteinizing hormone (LH), the rate of decrease in LH levels was significantly greater with goserelin by day 28. There are significant differences in endocrine response to goserelin and leuprolide in the 4 weeks following administration.
Notes
The publisher regrets that the article entitled Endocrine Response to a Single Injection of Goserelin 3.6 mg or Leuprolide 3.75 mg in Men with Prostrate Cancer by N. Tanaka, K. Fujimoto, Y. Hirao, K. Shimizu, S. Tsujimoto, and S. Samma in Archives of Andrology, Volume 53, Issue 2, pp 85–88 was published without amending several errors. The following is the correct version of the article in its entirety.